Biostar Pharmaceuticals, Inc. - BSPM

Biostar Pharmaceuticals, Inc. (BSPM)
Coverage: March 13, 2010 - March 13, 2011
Featured: March 13, 2010

There are two ways to treat patients infected with HepB in China. Interferon, a common treatment in the US, is very expensive. Without nationwide health care, Interferon is far too expensive for the average Chinese citizen. Enter Biostar Pharmaceuticals Inc (OTC BB: BSPM)- Biostar is the only Chinese company with an SFDA (Chinese version of our FDA) approval to market an over-the-counter treatment for HepB. It runs just over $1 per day, and has been proven highly effective in clinical trials. BSPM's Xin Aoxing Oleanolic Acid Capsule is the only product on the market that treats chronic hepatitis B disease at a price most Chinese can afford.

Latest Newsletter Editions

Sun, Sep 19, 2010 @ 07:09 am
Like Roberto Duran: Fund Managers Say No Más to China Stocks It was one of the most famous fights in history. November 25th, 1980- the Superdome in New Orleans- the rematch for the Welterweight championship of the world between Olympic Gold Medalist Sugar Ray Leonard and the sensational Roberto "Hands...
Tue, Aug 17, 2010 @ 11:08 am
For those interested parties- My #1 Pick- China Media Express (NASDAQ: CCME), is ringing the opening bell at NASDAQ tomorrow morning. Tune in if you are interested and up. More importantly, the company is barn storming both buy and sell side anyalysts and fund managers over the next few weeks throughout...
Fri, May 28, 2010 @ 09:05 am
Well, May has turned out to be an atrocious month for the bulls in the markets. All the major indexes were down about 8%- the worst May since 1962. The 2010 gains have been given back, and then some. The headline risk remains massive everyday between the European "Austerity" programs and the free fall...
Sun, May 16, 2010 @ 06:05 pm
Biostar Pharmaceuticals Inc. (NASDAQ: BSPM) Delivers Eye Popping Top Line in Q1 Profit Margins Don't Follow Suit Biostar Pharmaceuticals (NASDAQ: BSPM), one of the hottest China stocks of '09, delivered Q1 numbers Friday post close. Review below. First, the week in review. It was another ugly week in...
Wed, May 12, 2010 @ 08:05 pm
Early Returns on Hot China Followings: Universal Travel (NYSE: UTA), China Education Alliance (NYSE: CEU), and China Recycling (NASDAQ: CREG); a Mixed Bag and Lots Of Upside Biostar Pharmacueticals (NASDAQ: BSPM) To Come Three of the stocks listed as followed by the OTC Journal have reported Q1 earnings...

Click Here For More Newsletters on BSPM


Latest Blog Entries


Quote Data

Last Trade: Bid: 0.0000
Last Size: 0 Ask: 0.0000
Trade Time: Bid x Ask Size:
Change: +0.0000 (+0.00%) Day's Range: 0.00 - 0.00
Prev Close: 0.0000 52wk Range: 0.00 - 0.00
Open: 0.0000 P/E (ttm):
Volume: 0 EPS (ttm):
spacer [Chart]

Business Summary

Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary in China, develops, manufactures and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The Company's most popular product is its Xin Aoxing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to its hepatitis product, Biostar manufactures two broad-based OTC products, two prescription-based pharmaceuticals and thirteen nutrients. The Company has adopted international standards and is in the process of applying for two patents.


Myself and my associates started accumulating this a week ago. As a group, we own about 17,000 shares, purchased in the open market, from $3.50 to nearly $4. We'll buy and sell them anytime we want, and you might view this as a conflict of interest.

Recent News Headlines